ChiCTR2000033053 版本V1.0 版本创建时间2020/05/19 09:56:19 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2000033053 

最近更新日期:

Date of Last Refreshed on:

2020-05-19 09:56:10 

注册时间:

Date of Registration:

2020-05-19 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

早期清醒俯卧位对非机械通气的严重低氧饱和度新型冠状病毒肺炎患者的改善作用——一项单中心队列研究

Public title:

Efficacy of Early Prone Positioning in Non-Mechanical Ventilation COVID-19 Patients with Severe Hypoxia- a single-center prospective cohort study

注册题目简写:

English Acronym:

研究课题的正式科学名称:

早期俯卧位对新收治的严重低氧的新型冠状病毒肺炎患者的改善作用——一项单中心队列研究

Scientific title:

Efficacy of Early Prone Positioning in newly admitted COVID-19 patients with severe hypoxia: a single-center prospective cohort study

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

臧学峰 

研究负责人:

臧学峰 

Applicant:

zang xuefeng 

Study leader:

zang xuefeng 

申请注册联系人电话:

Applicant telephone:

15201231027

研究负责人电话:

Study leader's telephone:

15201231027

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

zangxuefeng@126.com

研究负责人电子邮件:

Study leader's E-mail:

zangxuefeng@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市海淀区羊坊店铁医路10号

研究负责人通讯地址:

北京市海淀区羊坊店铁医路10号

Applicant address:

10 tieyi road, yangfangdian, haidian district, Beijing, China

Study leader's address:

10 tieyi road, yangfangdian, haidian district, Beijing, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

首都医科大学附属北京世纪坛医院

Applicant's institution:

Beijing Shijitan Hospital, Capital Medical University

研究负责人所在单位:

首都医科大学附属北京世纪坛医院

Affiliation of the Leader:

Beijing Shijitan Hospital, Capital Medical University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

[2020]伦审字(0198)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

华中科技大学同济医学院附属协和医院医学伦理委员会

Name of the ethic committee:

Medical ethics committee, union medical college hospital, tongji medical college, huazhong university of science and technology

伦理委员会批准日期:

Date of approved by ethic committee:

2020-04-30 00:00:00

伦理委员会联系人:

褚圆圆

Contact Name of the ethic committee:

yuanyuan chu

伦理委员会联系地址:

湖北省武汉市解放大道1277号

Contact Address of the ethic committee:

1277 jiefang avenue, wuhan city, hubei province, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

华中科技大学同济医学院附属协和医院

Primary sponsor:

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

研究实施负责(组长)单位地址:

湖北省武汉市蔡甸区神龙大道58号

Primary sponsor's address:

No. 58, shenlong avenue, caidian district, wuhan city, hubei province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

湖北

市(区县):

武汉

Country:

China

Province:

Hubei

City:

单位(医院):

华中科技大学同济医学院附属协和医院

具体地址:

湖北省武汉市蔡甸区神龙大道58号

Institution
hospital:

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Address:

58 Shenlong Avenue, Caidian District, Wuhan

经费或物资来源:

Source(s) of funding:

Target disease:

COVID-19

Target disease code:

研究类型:

治疗研究

Study type:

Treatment study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

本研究拟对非机械通气严重低氧的新型冠状病毒肺炎患者采用俯卧位,观察10分钟、30分钟后患者呼吸频率、血氧饱和度改善情况。通过分析患者肺部影像学改善情况,进一步定性证实俯卧位对新冠肺炎的改善情况,并探讨患者是否实行俯卧位以及患者实行俯卧位的依从度与进一步呼吸支持的需求程度和预后的关系。  

Objectives of Study:

In this study, newly admitted COVID-19 patients with severe hypoxia were placed in the prone position group and non-prone position group, and the respiratory rate and blood oxygen saturation of the patients were observed after 10 minutes and 30 minutes.By analyzing the improvement of the patient's pulmonary imaging, the improvement of the prone position on covid-19 was further confirmed qualitatively, and the relationship between the patient's implementation of the prone position and the patient's compliance with the implementation of the prone position, the need for further respiratory support and the prognosis was explored.

药物成份或治疗方案详述:

俯卧位规范流程:患者符合入组条件,如果患者体质虚弱,呼吸频促,就建议患者坐在床旁的凳子上,然后尝试趴在床上;如果病情允许能配合的情况下,则建议患者双手抱肘,俯卧位趴在床上。10分钟后、30分钟后分别记录患者呼吸频率、血氧饱和度、心率和血压等情况。分别由两名医生评估患者对于俯卧位的执行情况,确定安全可靠性。建议患者每次1-2个小时,3-4次/日,连续5天。俯卧位总时间超过3h则开始入组追踪,每日记录俯卧位总时间,如患者在期间发生呼吸支持措施升级(采用经鼻高流量、无创正压通气、气管插管、气管切开)则终止清醒俯卧位。并继续追踪随访患者进一步呼吸机支持需求及预后。 

Description for medicine or protocol of treatment in detail:

Standardized prone position process: Patients in the group meet the requirements of enrollment. If the patient is weak and breathing frequently, it is recommended that the patient sit on the bench beside the bed and then try to lie on the bed prone. If the patient is allowed to cooperate, it is recommended that the patient hold his elbow with both hands and lie on the bed prone. Respiratory rate, oxygen saturation, heart rate and blood pressure were recorded after 10 minutes and 30 minutes respectively. Two physicians assessed the patient's performance in the prone position to determine safety and reliability. Patients are advised to spend 1-2 hours each, 3-4 times/day for 5 consecutive days. When the total prone position time was more than 3 hours, group tracking was started, and the total prone position time was recorded daily. If the patients had escalation of respiratory support measures (using nasal high flow, noninvasive positive pressure ventilation, endotracheal intubation, tracheotomy) during the period, the awake prone position was terminated. Further ventilator support needs and prognosis were followed up. 

纳入标准:

1、2019-nCoV核酸检测阳性,并具有明显的病毒性肺炎临床特征;2、严重缺氧,需要使用储氧面罩吸氧支持,脉搏氧饱和度能维持在90%左右;3、年龄18-80岁,具有自主活动能力的患者;4、本人或委托代理人签署知情同意书。

Inclusion criteria

1) The COVID-19 patient is diagnosis by nucleic acid detection, who has obvious clinical features of viral pneumonia; 2) The COVID-19 patient with severe hypoxia requires the use of oxygen storage masks, and whose pulse oxygen saturation can be maintained at about 90%; 3) The COVID-19 patient has the ability to move independently with age range from 18-80 years old; 4) Informed consent form of COVID-19 patient is signed by myself and agent.

排除标准:

1、存在无法耐受俯卧位或俯卧位极易造成伤害的情况,比如神经、精神问题,不能自主活动;尚未稳定的脊髓损伤或骨折(椎体骨折、骨盆骨折、多发骨折、连枷胸等);未缓解的颅内压升高;严重的烧伤;腹部手术后;腹腔高压;头面部损伤;气管切开;孕产妇。2、严重慢性肺病。3、血流动力学不稳定或合并其他器官功能衰竭需 ICU 监护治疗。4、临床预判无生存希望,仅进行临终关怀的病例,或者深度昏迷且在入院三小时内对支持治疗措施无反应的病例。

Exclusion criteria:

1. conditions that cannot be tolerated in prone positioning or prone positioning can easily cause injury, such as having neurological or mental problems, and inability to move autonomously; 2.Spinal cord injury or fracture (vertebral body fracture, pelvic fracture, multiple fractures, flail chest, etc.) that has not yet stabilized;Increased intracranial pressure without relief; Severe burned; Recently abdominal surgery; Abdominal hypertension; Head and face injuries; Tracheotomy; Maternal.2. Severe chronic lung disease.3. Unstable hemodynamic status or other organ failure should be treated in ICU.4. Patients with no hope of survival and only hospice care were clinically predicted, or those who were in a deep coma and did not respond to the supportive treatment measures within three hours after admission.

研究实施时间:

Study execute time:

From 2020-02-01 00:00:00 To 2020-03-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-02-01 00:00:00 To 2020-04-30 00:00:00  

干预措施:

Interventions:

组别:

俯卧位组

样本量:

23

Group:

prone position group

Sample size:

干预措施:

俯卧位

干预措施代码:

Intervention:

prone position

Intervention code:

组别:

非俯卧位组

样本量:

37

Group:

Non-Prone Position

Sample size:

干预措施:

干预措施代码:

Intervention:

non

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

湖北 

市(区县):

武汉 

Country:

China 

Province:

Hubei 

City:

Wuhan 

单位(医院):

华中科技大学同济医学院附属协和医院西院区 

单位级别:

三甲医院 

Institution
hospital:

West area of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Level of the institution:

Tertiary A Hospital

测量指标:

Outcomes:

指标中文名:

脉搏氧饱和度

指标类型:

主要指标

Outcome:

pulse oxygen saturation

Type:

Primary indicator

测量时间点:

基础状态,俯卧位后10分钟和30分钟后

测量方法:

指夹式血氧饱和度脉搏光电传感器检测法

Measure time point of outcome:

Base state, 10 minutes and 30 minutes after prone position

Measure method:

pulse and oxygen saturation photoelectric sensor detection method

指标中文名:

呼吸频率

指标类型:

主要指标

Outcome:

respiratory rate

Type:

Primary indicator

测量时间点:

基础状态,俯卧位后10分钟和30分钟后

测量方法:

30s观察法

Measure time point of outcome:

Base state, 10 minutes and 30 minutes after prone position

Measure method:

observation for 30 second

指标中文名:

ROX指数

指标类型:

主要指标

Outcome:

ROX index

Type:

Primary indicator

测量时间点:

基础状态,俯卧位后10分钟和30分钟后

测量方法:

计算

Measure time point of outcome:

Base state, 10 minutes and 30 minutes after prone position

Measure method:

calculate

指标中文名:

胸部CT

指标类型:

次要指标

Outcome:

CT Scan-Chest

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

转归

指标类型:

次要指标

Outcome:

outcome

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

压疮

指标类型:

副作用指标

Outcome:

pressure sores

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

呕吐

指标类型:

副作用指标

Outcome:

emesis

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

俯卧位患者来自其中一个病区,对照组来自另外两个病区。三个病区属于同一支医疗队不同医师负责,治疗方面均按照国家卫建委医政医管局发布《新型冠状病毒感染的肺炎诊疗方案》以及WHO临时指南进行。

Randomization Procedure (please state who generates the random number sequence and by what method):

The prone patients were from one of the wards and the control group was from two other wards. The three wards belong to the same medical team and different physicians are responsible for the treatment in accordance with the "Pneumonia Diagnosis and Treatment Plan for New Coronavirus Infection" issued by

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

数据库建立成功后分享IPD

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

will share IPD by url after we complete the database

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

主要研究者臧学峰、王倩、周华负责收集数据,并保管于研究USB中。臧学峰、王倩、周华确保数的真实、准确和安全。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Hua Zhou, Xuefeng Zang and Qian Wang will collect and manage the data as PI by using excel and rearch USB. Hua Zhou, Xuefeng Zang and Qian Wang has resposiblity to ensure the accuracy, genuity and saftey of the data.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2020-05-19 09:56:10